A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer

INTRODUCTION: The aim of this prospective phase II study was to evaluate the efficacy and safety of biweekly docetaxel plus androgen-deprivation therapy (ADT) in patients with metastatic castration-naïve prostate cancer (mCNPC). PATIENTS AND METHODS: Patients with histologically-proven, previously-u...

Descripción completa

Detalles Bibliográficos
Autores principales: Byeon, Seonggyu, Kim, Hongsik, Jeon, Hwang Gyun, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Lee, Soon Il, Park, Se Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628395/
https://www.ncbi.nlm.nih.gov/pubmed/34839812
http://dx.doi.org/10.1186/s12885-021-09018-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628395/
https://www.ncbi.nlm.nih.gov/pubmed/34839812
http://dx.doi.org/10.1186/s12885-021-09018-6

Ejemplares similares